A detailed history of Wolverine Trading, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 15,362 shares of STIM stock, worth $44,857. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,362
Previous 11,220 36.92%
Holding current value
$44,857
Previous $41,000 29.27%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 18, 2025

BUY
$3.32 - $4.65 $13,751 - $19,260
4,142 Added 36.92%
15,362 $53,000
Q1 2025

May 15, 2025

BUY
$1.49 - $5.54 $16,717 - $62,158
11,220 New
11,220 $41,000
Q4 2023

Feb 14, 2024

BUY
$1.05 - $2.9 $11,739 - $32,422
11,180 New
11,180 $32,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $78.9M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.